Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

22nd Nov 2012 10:10

RNS Number : 7782R
Clinigen Group plc
22 November 2012
 



 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Clinigen Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Grandeur Peak Global Advisors, LLC

4. Full name of shareholder(s)  (if different from 3.):iv

FIT, Grandeur Peak Global Opportunities Fund

FIT, Grandeur Peak International Opportunities Fund

Grandeur Peak Global Opportunities, LP

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

October 17, 2012

6. Date on which issuer notified:

November 21, 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B89J2419

2,460,000

2,460,000

2,488,000

2,488,000

3.01%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,488,000

3.01%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

As of October 17, 2012, our total position is 3.01%. Specifically:

FIT, Grandeur Peak Global Opportunities Fund owns 1,355,000 shares or 1.6%

FIT, Grandeur Peak International Opportunities Fund owns 636,000 shares or 0.8%

Grandeur Peak Global Opportunities, LP owns 469,000 shares or 0.6%

Proxy Voting:

10. Name of the proxy holder:

Grandeur Peak Global Advisors, LLC

11. Number of voting rights proxy holder will ceaseto hold:

0

12. Date on which proxy holder will cease to holdvoting rights:

Not applicable

13. Additional information:

Grandeur Peak Global Advisors

136 South Main Street, Suite 720

Salt Lake City, UT 84101

14. Contact name:

Amy Hone, Vice President Trading & Operations

15. Contact telephone number:

801-384-0007

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Contact address

(registered office for legal entities)

 

Phone number & email

 

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEFAAESAFFF

Related Shares:

CLIN.L
FTSE 100 Latest
Value8,417.34
Change2.09